This clinical trial evaluates the effects of aromatherapy on anxiety and pain in children having their ports accessed. Port access can cause pain and anxiety, especially for children. The addition of aromatherapy may help reduce children’s anxiety and pain when having their ports accessed.
Additional locations may be listed on ClinicalTrials.gov for NCT05696899.
See trial information on ClinicalTrials.gov for a list of participating sites.
PRIMARY OBJECTIVE:
I. To determine if the use of aromatherapy promotes improved comfort in the setting of anxiety and pain surrounding port access in pediatric oncology patients ages 4 years to 18 years.
SECONDARY OBJECTIVE:
I. To compare participants’ response to comfort promotion in light of anxiety and pain surrounding port access between age groups.
OUTLINE: Patients are randomized to 1 of 2 arms.
ARM I: Patients inhale STILL aromatherapy and receive current supportive interventions at each lab for 3-5 months.
ARM II: Patients receive current supportive interventions within the lab at each lab visit for 3-5 months.
After completion of study, patients are followed up for 7 day.
Trial PhaseNo phase specified
Trial Typesupportive care
Lead OrganizationStanford Cancer Institute Palo Alto
Principal InvestigatorAnnette Nasr
